Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Comparing Copy Number Variations and SNPs02:26

Comparing Copy Number Variations and SNPs

Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Gene Evolution - Fast or Slow?02:05

Gene Evolution - Fast or Slow?

The genomes of eukaryotes are punctuated by long stretches of sequence which do not code for proteins or RNAs. Although some of these regions do contain crucial regulatory sequences, the vast majority of this DNA serves no known function. Typically, these regions of the genome are the ones in which the fastest change, in evolutionary terms, is observed, because there is typically little to no selection pressure acting on these regions to preserve their sequences.
In contrast, regions which code...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

IQ-TREE 3: phylogenomic inference software using complex evolutionary models.

Molecular biology and evolution·2026
Same author

Systemic inflammatory perturbations triggered by neuropathic pain in L5 compressed mouse and rat model.

Journal of orthopaedic translation·2026
Same author

piqtree: a python package for seamless phylogenetic inference with IQ-TREE.

Molecular biology and evolution·2026
Same author

Artificial anterolateral ligament reconstruction provides similar knee kinematics as compared to an autologous reconstruction and a lateral extra-articular tenodesis.

Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA·2025
Same author

Outperformance of Combined Artificial Anterolateral Ligament and ACL Reconstruction Compared With Isolated Artificial ACL Reconstruction in Knees With Anterolateral Structure and ACL Deficiency: A Biomechanical Analysis.

Orthopaedic journal of sports medicine·2025
Same author

Spectral cluster supertree: fast and statistically robust merging of rooted phylogenetic trees.

Frontiers in molecular biosciences·2024

Related Experiment Video

Updated: Jun 3, 2026

Following the Dynamics of Structural Variants in Experimentally Evolved Populations
04:52

Following the Dynamics of Structural Variants in Experimentally Evolved Populations

Published on: February 3, 2023

Exploiting CpG hypermutability to identify phenotypically significant variation within human protein-coding genes.

Hua Ying1, Gavin Huttley

  • 1Department of Genome Biology, John Curtin School of Medical Research, The Australian National University, Canberra, ACT 0200, Australia.

Genome Biology and Evolution
|March 15, 2011
PubMed
Summary
This summary is machine-generated.

CpG dinucleotides in human DNA are prone to mutation. Our study identifies functionally important CpG sites, revealing that those under strong selection are linked to genetic diseases.

More Related Videos

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)
11:35

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)

Published on: August 21, 2016

Related Experiment Videos

Last Updated: Jun 3, 2026

Following the Dynamics of Structural Variants in Experimentally Evolved Populations
04:52

Following the Dynamics of Structural Variants in Experimentally Evolved Populations

Published on: February 3, 2023

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)
11:35

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)

Published on: August 21, 2016

Area of Science:

  • Genomics
  • Population Genetics
  • Molecular Evolution

Background:

  • CpG dinucleotides exhibit disproportionate representation in human genetic variation due to 5-methyl-cytosine (5mC) hypermutability.
  • Population genetic theory posits that codon positions with high cross-species CpG frequency are subject to stronger purifying selection.

Purpose of the Study:

  • To identify candidate functionally important exonic nucleotides by exploiting 5mC hypermutability.
  • To measure mutagenic and selective processes affecting CpG dinucleotides within exonic sequences.

Main Methods:

  • Applied codon substitution models with context-dependent parameters within a phylogeny-based maximum likelihood inference framework.
  • Validated models on yeast genes (lacking DNA methylation) and analyzed over 12,000 protein-coding genes from four primate lineages.
  • Adjusted for mutation influences and amino acid properties to assess purifying selection on CpG-containing codons.

Main Results:

  • Confirmed the systemic influence of 5mC hypermutability on primate gene divergence.
  • Demonstrated that CpG-containing codons are under greater purifying selection in primates after accounting for confounding factors.
  • Identified significant enrichment of genes with suppressed nonsynonymous CpG changes in Online Mendelian Inheritance in Man (OMIM).

Conclusions:

  • Developed a method to rank candidate phenotypically influential CpG positions in human genes.
  • Approximately 20% of human exonic CpG dinucleotides are candidates for both hypermutability and disease association.
  • Highlights the role of CpG dinucleotides in human genetic variation and disease etiology.